The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

On Thursday, the “Make America Healthy Again” commission released its first report on the potential contributors of chronic ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

After a heart attack, patients with ADHD may have poorer outcomes due to low participation in follow-ups and behavioral risk ...

A subretinal injection of ATSN-201 gene therapy demonstrated promising results in patients with X-linked retinoschisis in a ...

Shakira J. Grant, MBBS, MSCR, is working to make visible the lived experiences and real-world barriers that patients with ...

It is a challenging time to be a women’s health care provider, but there are ways physicians can reclaim their power while ...

A machine learning model may be reliable for determining risk for postpartum depression, underscoring the need for greater ...

During his presidential inauguration at the ACOG Annual Clinical & Scientific Meeting, Steven J. Fleischman, MD, MBA, FACOG, ...

Studies are needed to assess the delivery and efficacy of psychoeducation programs focused on the menopause transition for ...

Nearly half of people with advanced cancer receive aggressive care at the end of life, a rate little changed from a decade ...